1. Pelvic infections: 107 pateints took F3 for three weeks and all were cured.2. Pneumonia: 67 patients took F3 or its modification for up to three days and 56 cured (83.58 percent) but 11 did not improve (16.41 percent).3. Bacillary dysentery: Five reports on 468 bacillary dysentery patients took F3 or its modification for up to two weeks and 417 cured (89.10 percent), 43 improved (9.18 percent) and 8 did not improve (1.71 percent). Pediatric bacillary dysentery: 51 children took F3 and 38 cured (74.50 percent), 10 improved (19.60 percent) and three did not. (5.9 percent).4. Amebic dysentery: Of 210 patients treated with F3 from three to 30 days, found 200 patients were cured (95.23 percent) , 7 improved (3.33 percent) and 3 deaths (1.43 percent). 5. Enteritis: 194 patients were treated with F3 and 187 were cured or improved (96.39 percent), six did not improve (3.09 percent) and one death.6. Urinary tract infections: 117 patients took F3 for 10 days and 70 cured (59.82 percent), 34 improved (29.05 percent) and 13 did not (11.11 percent).
